MAGE-A3 Activators
MAGE-A3 activators represent a distinctive chemical class of compounds, garnering attention in the realm of immunological research. These activators are designed to interact with the MAGE-A3 gene, which belongs to the melanoma-associated antigen (MAGE) family. Typically expressed during the development of testis and placenta, the MAGE-A3 gene is characterized by its overexpression in certain pathological conditions. MAGE-A3 activators serve as key mediators in modulating the immune response associated with this gene.
Functionally, MAGE-A3 activators operate by engaging with the MAGE-A3 protein or its associated peptides, prompting a series of immune reactions within the organism. This cascade includes the activation of cytotoxic T cells and the production of specific antibodies. The ultimate objective of these immune responses is to identify and eliminate cells that express MAGE-A3, thereby influencing the progression of the condition at hand. MAGE-A3 activators hold promise as innovative tools in the field of immunology, exploiting the body's innate defense mechanisms by targeting a specific antigen whose expression is altered under specific pathological conditions. This avenue of research has garnered significant scientific interest, offering fresh insights into how immunological mechanisms can be harnessed to understand and address complex biological phenomena beyond the scope of conventional interventions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid, another histone deacetylase inhibitor, can change gene expression patterns and may induce the expression of tumor antigens such as MAGE-A3. | ||||||
Phenethyl isothiocyanate | 2257-09-2 | sc-205801 sc-205801A | 5 g 10 g | $104.00 $183.00 | 2 | |
This compound can modify gene expression through the induction of stress response pathways that might include the activation of genes like MAGE-A3. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate, a short-chain fatty acid, is a histone deacetylase inhibitor that can lead to the upregulation of certain genes, potentially including MAGE-A3, by affecting chromatin structure. | ||||||
Temozolomide | 85622-93-1 | sc-203292 sc-203292A | 25 mg 100 mg | $91.00 $255.00 | 32 | |
Although primarily known for its alkylating properties, it can cause cellular stress, which may influence gene expression patterns, possibly affecting the expression of genes like MAGE-A3. | ||||||
Arsenic(III) oxide | 1327-53-3 | sc-210837 sc-210837A | 250 g 1 kg | $89.00 $228.00 | ||
It induces various cellular responses, including alterations in gene expression, and could potentially affect MAGE-A3 expression. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
This proteasome inhibitor affects numerous cellular signaling pathways and might induce the expression of genes like MAGE-A3 as part of a stress response or altered immune signaling. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, a derivative of vitamin A, is known to influence gene expression through its action as a transcriptional regulator, which could potentially lead to MAGE-A3 expression in certain cellular contexts. | ||||||